Position in GLUE
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$7,284
+$2,333 QoQ
Shares Held
301
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#173
of 191 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Westfuller Advisors, LLC holds $67,869 across 7 Biotechnology names. GLUE ranks #4 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KOD |
Kodiak Sciences Inc.
|
692 | $26,960 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
24 | $14,964 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
22 | $10,928 | |
| 4 | GLUE |
Monte Rosa Therapeutics, Inc.
This page
|
301 | $7,284 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
13 | $4,109 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9 | $2,709 | |
| 7 | CAPR |
Capricor Therapeutics, Inc.
|
38 | $915 |
All Filings in GLUE
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,284 | 301 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $4,951 | 301 | Shares | Sole | 2026-04-28 | |
| No filing history on record for this holder in this stock. | ||||||